Theralase Technologies Inc (TLTFF)

$0.23 -0.01 (-2.17%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 81,700
Avg Vol 102,686
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 79%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. The company operates through Drug Division and Device Division segments. It designs, develops, manufactures, and markets super-pulsed laser technology for the healing of chronic knee pain, as well...

Industry: Medical Devices
Sector: Healthcare
Phone: 416 699 5273
Fax: 416 699 5250
Address:
41 Hollinger Road, Toronto, Canada
RobertX916
RobertX916 Mar. 20 at 5:43 PM
$TLTFF Adding for a long term hold. I like what I have been reading for this and the bio sector…. Gotta buy something even during a shooting war…
0 · Reply
Buy_SoFi
Buy_SoFi Mar. 19 at 4:13 PM
$IBRX Keep an eye on $TLTFF (Theralase) while we wait for more Anktiva news. They have VERY competitive numbers for NMIBC and working on HSV treatment better than anything on the market. Worth putting on your watchlist.
0 · Reply
Buy_SoFi
Buy_SoFi Mar. 17 at 1:57 PM
$TLTFF <---- Keep an eye on this one $GILD $IBRX $MRK $TEVA HSV treatment far superior to current Acyclovir. NMIBC cure very competitive with Anktiva (Ruvidar)
1 · Reply
Buy_SoFi
Buy_SoFi Mar. 17 at 12:54 AM
$TLTFF
0 · Reply
newsfile_corp
newsfile_corp Mar. 10 at 11:01 AM
https://nfne.ws/287848 $TLTFF $TLT.TSXV #Biotech #BiotechInvesting #BladderCancer #CancerResearch #Oncology #Chemicals #Pharmaceutical #Bio
0 · Reply
prismmarketview
prismmarketview Mar. 9 at 6:42 PM
Theralase $TLTFF Reports Promising Results for X-Ray-Activated Rutherrin in Bladder Cancer Research https://prismmarketview.com/theralase-reports-promising-results-for-x-ray-activated-rutherrin-in-bladder-cancer-research/
0 · Reply
newsfile_corp
newsfile_corp Mar. 9 at 11:01 AM
https://nfne.ws/286595 $TLTFF $TLT.TSXV #Biotech #BiotechInvesting #BladderCancer #CancerResearch #Oncology #Chemicals #Pharmaceutical #Bio
0 · Reply
Buy_SoFi
Buy_SoFi Mar. 2 at 10:47 PM
$IBRX You will want to include Ruvidar by $TLTFF to that list. Just about to get approved. Ruvidar Monotherapy CR of +64% (after a SINGLE treatment) and starting a new cohort with combined treatment with Adlistarin. I'm building my position in both.
1 · Reply
Buy_SoFi
Buy_SoFi Feb. 26 at 7:44 PM
$IBRX $TLTFF is pretty damn close. Super early too. (I hold both)
1 · Reply
newsfile_corp
newsfile_corp Feb. 20 at 12:02 PM
https://nfne.ws/284551 $TLTFF $TLT.TSXV #Chemicals #Pharmaceutical #Biotechnology #HealthCare #Medical #Pharmaceuticals #Technology #OTC #O
0 · Reply
Latest News on TLTFF
No data available.
RobertX916
RobertX916 Mar. 20 at 5:43 PM
$TLTFF Adding for a long term hold. I like what I have been reading for this and the bio sector…. Gotta buy something even during a shooting war…
0 · Reply
Buy_SoFi
Buy_SoFi Mar. 19 at 4:13 PM
$IBRX Keep an eye on $TLTFF (Theralase) while we wait for more Anktiva news. They have VERY competitive numbers for NMIBC and working on HSV treatment better than anything on the market. Worth putting on your watchlist.
0 · Reply
Buy_SoFi
Buy_SoFi Mar. 17 at 1:57 PM
$TLTFF <---- Keep an eye on this one $GILD $IBRX $MRK $TEVA HSV treatment far superior to current Acyclovir. NMIBC cure very competitive with Anktiva (Ruvidar)
1 · Reply
Buy_SoFi
Buy_SoFi Mar. 17 at 12:54 AM
$TLTFF
0 · Reply
newsfile_corp
newsfile_corp Mar. 10 at 11:01 AM
https://nfne.ws/287848 $TLTFF $TLT.TSXV #Biotech #BiotechInvesting #BladderCancer #CancerResearch #Oncology #Chemicals #Pharmaceutical #Bio
0 · Reply
prismmarketview
prismmarketview Mar. 9 at 6:42 PM
Theralase $TLTFF Reports Promising Results for X-Ray-Activated Rutherrin in Bladder Cancer Research https://prismmarketview.com/theralase-reports-promising-results-for-x-ray-activated-rutherrin-in-bladder-cancer-research/
0 · Reply
newsfile_corp
newsfile_corp Mar. 9 at 11:01 AM
https://nfne.ws/286595 $TLTFF $TLT.TSXV #Biotech #BiotechInvesting #BladderCancer #CancerResearch #Oncology #Chemicals #Pharmaceutical #Bio
0 · Reply
Buy_SoFi
Buy_SoFi Mar. 2 at 10:47 PM
$IBRX You will want to include Ruvidar by $TLTFF to that list. Just about to get approved. Ruvidar Monotherapy CR of +64% (after a SINGLE treatment) and starting a new cohort with combined treatment with Adlistarin. I'm building my position in both.
1 · Reply
Buy_SoFi
Buy_SoFi Feb. 26 at 7:44 PM
$IBRX $TLTFF is pretty damn close. Super early too. (I hold both)
1 · Reply
newsfile_corp
newsfile_corp Feb. 20 at 12:02 PM
https://nfne.ws/284551 $TLTFF $TLT.TSXV #Chemicals #Pharmaceutical #Biotechnology #HealthCare #Medical #Pharmaceuticals #Technology #OTC #O
0 · Reply
newsfile_corp
newsfile_corp Feb. 17 at 12:00 PM
https://nfne.ws/284094 $TLTFF $TLT.TSXV #Biotech #BiotechInvesting #BiotechStocks #HealthcareInvesting #LifeSciences #Chemicals #Pharmaceut
0 · Reply
Buy_SoFi
Buy_SoFi Feb. 11 at 5:55 PM
$TLTFF They are sitting at 90 patients at the moment with more coming up with the joint study with Ferring
0 · Reply
newsfile_corp
newsfile_corp Feb. 10 at 12:00 PM
https://nfne.ws/283299 $TLTFF $TLT.TSXV #AUA #BiotechInvesting #BladderCancer #ClinicalData #Urology #Chemicals #Pharmaceutical #Biotechnol
0 · Reply
Buy_SoFi
Buy_SoFi Feb. 9 at 10:16 PM
$TLTFF Company is working in NASDAQ listing by end of year. 🤞🏻
0 · Reply
kubota2323
kubota2323 Feb. 9 at 4:40 PM
$TLTFF any chance this pos gets uplisted ?
0 · Reply
Buy_SoFi
Buy_SoFi Feb. 9 at 3:39 PM
$TLTFF <------ This one will surprise everyone one of these days with an Accelerated Approval out of nowhere. $IBRX $CGON $NVO Should also trade on NASDAQ by EoY. $XBI
0 · Reply
Buy_SoFi
Buy_SoFi Feb. 5 at 10:24 PM
$TLTFF $QQQ $SPY check this one out and thank me later ----> $TLTFF
0 · Reply
Buy_SoFi
Buy_SoFi Feb. 5 at 7:44 PM
$TLTFF multi-multi-bagger in the making. Best #'s in the industry for NMIBC treatment 💥 $QQQ $SPY Buy now for dirt cheap and thank me later.
1 · Reply
PhantomZ
PhantomZ Feb. 4 at 11:27 PM
$APP Why the drop? This should bounce hard if ER positive, if not may drop another 20% IMO? This went from 9$ to $700 in 3 yrs. My top pick to repeat a nice 50-100 bagger in 1-2 yrs is $TLTFF ( microcap Cancer Biotech).. IMHO do your DD.
0 · Reply
PhantomZ
PhantomZ Feb. 4 at 10:15 PM
$APP SP went from $9 to $700 in 3 yrs, I expect $TLTFF ( cancer biotech) to have a similar move in next 1-2 yrs. IMHO do your DD
1 · Reply
Buy_SoFi
Buy_SoFi Feb. 4 at 6:38 PM
$TLTFF Updated numbers just came out. Getting better and better. Pressure and momentum building up, about to blow up. $CGON $IBRX Get in and multi bag
0 · Reply
newsfile_corp
newsfile_corp Feb. 4 at 12:01 PM
https://nfne.ws/282520 $TLTFF $TLT.TSXV #BiotechInvesting #BladderCancer #ClinicalData #LifeSciences #Oncology #Chemicals #Pharmaceutical #
0 · Reply